UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Personalized, tumor‐informed, circulating tumor DNA assay for detecting minimal residual disease in non‐small cell lung cancer patients receiving curative treatments

Thoracic cancer, 2024-05, Vol.15 (13), p.1095-1102

2024

Volltextzugriff (PDF)

Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review

Frontiers in endocrinology (Lausanne), 2024, Vol.15, p.1304188-1304188

2024

Volltextzugriff (PDF)

Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer

Annals of Transplantation, 2023-12, Vol.28, p.e941301-e941301-10

2023

Volltextzugriff (PDF)

Redefining Clinical Hyperprogression: The Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy

Clinical lung cancer, 2024-06, Vol.25 (4), p.365-375.e14

2024

Volltextzugriff (PDF)

Current and future role of double-lung transplantation for bilateral lung cancer

Transplantation reviews (Philadelphia, Pa.), 2023-07, Vol.37 (3), p.100772-100772, Article 100772

2023

Volltextzugriff (PDF)

38 Serum proteomics signature and its association with immune-related toxicities and survival in patients with non-small cell lung cancers (NSCLC) receiving immunotherapy

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A43-A43

2023

Volltextzugriff (PDF)

1299 Radiomics features to predict tumor response and biomarker status in non-small cell lung cancer (NSCLC) patients treated with immunotherapy

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1444-A1444

2023

Volltextzugriff (PDF)

Artificial intelligence (AI) analysis of tumor-infiltrating lymphocytes (TILs) in hematoxylin and eosin (H&E) slides to explore immune phenotypes in papillary thyroid cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.6100-6100

2023

Volltextzugriff (PDF)

Incidence, landscape and survival outcome of de novo malignancy after double lung transplantation

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10574-10574

2023

Volltextzugriff (PDF)

Inverse association of post-transplant malignancy and graft failure on survival outcome following double lung transplantation

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10629-10629

2023

Volltextzugriff (PDF)

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The desmoid tumors (cohort 27)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11516-11516

2023

Volltextzugriff (PDF)

Abstract CT051: Double lung transplant registry aimed for lung-limited malignancies (DREAM) - a prospective registry study of bilateral lung transplantation for medically refractory cancers confined to the lungs

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT051-CT051

2023

Volltextzugriff (PDF)

Artificial intelligence (AI) –powered H&E whole-slide image (WSI) analysis of tertiary lymphoid structure (TLS) correlates with immune phenotype and related molecular signatures in non–small-cell lung cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e20520-e20520

2023

Volltextzugriff (PDF)

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The vulvar cancers

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5517-5517

2023

Volltextzugriff (PDF)

Systematic review and meta-analysis of accuracy of tumor origin detection in blood cell-free DNA (cfDNA)-based multi-cancer early detection (MCED) assays in the general population

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e15053-e15053

2023

Volltextzugriff (PDF)

Systematic review and meta-analysis of the accuracy and applicability of blood-based multi-cancer early detection (MCED) in the general population

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3069-3069

2023

Volltextzugriff (PDF)

Preventing healthcare professional burnout in oncology: How creative patient encouragement can go both ways

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.11020-11020

2022

Volltextzugriff (PDF)

The symbiosis of healthcare professionals and patients: Understanding the dynamics of long-term care relationships between healthcare professionals and patients in oncology

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.12134-12134

2022

Volltextzugriff (PDF)

Abstract CT278: [DREAM] Double lung transplant registry aimed for lung-limited malignancies - a prospective registry study for medically refractory cancers

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT278-CT278

2024

Volltextzugriff (PDF)

Abstract 946: Landscape of HRD aberration in EGFR mutated lung cancer and the role of PARP-inhibitor in EGFR mutated lung cancer with HRD aberration

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.946-946

2024

Volltextzugriff (PDF)

Abstract 2397: Double lung transplantation (DLT) in patients with stage IVA lung-limited non-small cell lung carcinoma (NSCLC): A case series

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.2397-2397

2024

Volltextzugriff (PDF)

Abstract 6495: Lenvatinib as a potential treatment option for invasive mucinous lung adenocarcinoma

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6495-6495

2024

Volltextzugriff (PDF)

Machine learning models based on radiomics features to predict treatment response, biomarker status, and bone metastasis in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21217-e21217

2023

Volltextzugriff (PDF)

Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive Mucinous Adenocarcinoma

Clinical lung cancer, 2024-05

2024

Volltextzugriff (PDF)

Abstract CT165: Phase II study of nivolumab and ipilimumab for treatment of metastatic/recurrent adenoid cystic carcinoma (ACC) of all anatomic sites of origin and other malignant salivary gland tumors

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT165-CT165

2023

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

Immunotherapy
(7)
Humans
(5)
Life Sciences & Biomedicine
(5)
Lung Cancer
(5)
Science & Technology
(5)
Chemotherapy
(3)
Female
(3)
Middle Aged
(3)
Adult
(2)
Aged
(2)
Aged, 80 And Over
(2)
Biomarkers
(2)
Cancer Therapies
(2)
Carcinoma, Non-Small-Cell Lung - Pathology
(2)
Immunology
(2)
Incidence
(2)
Lung
(2)
Lung Neoplasms - Pathology
(2)
Lung Neoplasms - Surgery
(2)
Lung Transplantation
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Personalized, tumor‐informed, circulating tumor DNA assay for detecting minimal residual disease in non‐small cell lung cancer patients receiving curative treatments

Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review

Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer

Redefining Clinical Hyperprogression: The Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy

Current and future role of double-lung transplantation for bilateral lung cancer

38 Serum proteomics signature and its association with immune-related toxicities and survival in patients with non-small cell lung cancers (NSCLC) receiving immunotherapy

1299 Radiomics features to predict tumor response and biomarker status in non-small cell lung cancer (NSCLC) patients treated with immunotherapy

Artificial intelligence (AI) analysis of tumor-infiltrating lymphocytes (TILs) in hematoxylin and eosin (H&E) slides to explore immune phenotypes in papillary thyroid cancer

Incidence, landscape and survival outcome of de novo malignancy after double lung transplantation

Inverse association of post-transplant malignancy and graft failure on survival outcome following double lung transplantation

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The desmoid tumors (cohort 27)

Abstract CT051: Double lung transplant registry aimed for lung-limited malignancies (DREAM) - a prospective registry study of bilateral lung transplantation for medically refractory cancers confined to the lungs

Artificial intelligence (AI) –powered H&E whole-slide image (WSI) analysis of tertiary lymphoid structure (TLS) correlates with immune phenotype and related molecular signatures in non–small-cell lung cancer

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The vulvar cancers

Systematic review and meta-analysis of accuracy of tumor origin detection in blood cell-free DNA (cfDNA)-based multi-cancer early detection (MCED) assays in the general population

Systematic review and meta-analysis of the accuracy and applicability of blood-based multi-cancer early detection (MCED) in the general population

Preventing healthcare professional burnout in oncology: How creative patient encouragement can go both ways

The symbiosis of healthcare professionals and patients: Understanding the dynamics of long-term care relationships between healthcare professionals and patients in oncology

Abstract CT278: [DREAM] Double lung transplant registry aimed for lung-limited malignancies - a prospective registry study for medically refractory cancers

Abstract 946: Landscape of HRD aberration in EGFR mutated lung cancer and the role of PARP-inhibitor in EGFR mutated lung cancer with HRD aberration

Abstract 2397: Double lung transplantation (DLT) in patients with stage IVA lung-limited non-small cell lung carcinoma (NSCLC): A case series

Abstract 6495: Lenvatinib as a potential treatment option for invasive mucinous lung adenocarcinoma

Machine learning models based on radiomics features to predict treatment response, biomarker status, and bone metastasis in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs)

Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive Mucinous Adenocarcinoma

Abstract CT165: Phase II study of nivolumab and ipilimumab for treatment of metastatic/recurrent adenoid cystic carcinoma (ACC) of all anatomic sites of origin and other malignant salivary gland tumors

Suchergebnisse filtern